Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 51

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 51
---
 average Total Compensation as reported in the Summary Compensation Table for the 2024.

(b) Represents the average aggregate grant date fair value of the stock awards and option awards granted to the non-PEO NEOs during 2024, computed in accordance with FASB ASC 718, as reported in the Summary Compensation Table for 2024.

(c) Represents the average aggregate fair value as of 2024 fiscal year-end of the non-PEO NEO's outstanding and unvested stock awards and option awards granted during 2024, computed in accordance with FASB ASC 718.

(d) Represents the average aggregate change in fair value during 2024 of the outstanding and unvested stock awards and option awards held by the non-PEO NEOs as of the last day of 2024, computed in accordance with FASB ASC 718 and, for awards subject to performance-based vesting conditions as of 2024 fiscal year end, based on the probable outcome of such performance-based vesting conditions as of the last day of 2024, and for performance-based awards with performance periods ending in 2024, based on actual attainment as of the end of the applicable performance period.

(e) Represents the average aggregate fair value at vesting of the stock awards and option awards that were granted to the non-PEO NEOs and vested during 2024, computed in accordance with FASB ASC 718.

(f) Represents the average aggregate change in fair value, measured from 2023 fiscal year-end to the vesting date, of each stock award and option award held by the non-PEO NEOs that was granted in a prior fiscal year and which vested during 2024, computed in accordance with FASB ASC 718.

(g) Represents the average aggregate fair value as of the last day of 2023 of the non-PEO NEOs stock awards and option awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in 2024, computed in accordance with FASB ASC 718.

Relationship Between Compensation Actually Paid and Financial Performance Measures

The following graphs illustrate the relationship between the pay and performance figures that are included in the pay versus performance tables above.

<div align='center'>36

37</div>

Tabular List of Most Important Financial Performance Measures

The following list of financial performance measures were used by the Company to link executive compensation actually paid to company performance for 2024:

– Adjusted EBITDA